Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermine synthase pseudogene (ENSG00000232389) is a processed, nonfunctional DNA segment homologous to the spermine synthase gene. Like other processed pseudogenes, it arose via reverse transcription and genomic integration of mRNA from the functional gene but lacks the required regulatory sequences and coding integrity to produce active protein. Pseudogenes such as this do not have straightforward biological functions and are not considered therapeutic targets, receptors, or classical molecular entities of interest in drug development[1][3][5]. There is currently no evidence suggesting that this specific pseudogene plays any regulatory role or is relevant as a disease biomarker, although some pseudogenes can sometimes influence gene regulation or disease progression in other contexts[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermine synthase pseudogene.